Omadacycline is used as an antibiotic to treat various bacterial infections. It is particularly effective against community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). The medication works by inhibiting bacterial protein synthesis, which helps to stop the growth and spread of bacteria. Omadacycline is often chosen for its broad-spectrum activity and its ability to be administered both intravenously and orally, providing flexibility in treatment options. It is especially useful for patients who may have allergies or intolerances to other antibiotics, such as tetracyclines. Additionally, it is effective against certain drug-resistant bacteria, making it a valuable option in managing difficult-to-treat infections.